RaviDhingraMD
Cardiology • Milwaukee, WIAdult Congenital Heart Disease, Heart Failure & Transplantation
Associate Professor of Medicine, UW-Madison
Dr. Dhingra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-6000Fax+1 414-805-6280
Summary
- Advanced Heart Failure and Transplant Cardiologist
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Cardiovascular Disease, 2009 - 2012
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2000 - 2003
ArMed Forces Medical College PuneClass of 1996
Boston Medical CenterFellowship, Research Fellow, Framingham Heart Study
Brigham and Women's HospitalFellowship, Preventive Cardiology
Tufts Medical CenterFellowship, Advanced Heart Failure and Transplant Cardiology
Certifications & Licensure
NH State Medical License 2006 - Present
IL State Medical License 2014 - 2026
WI State Medical License 2013 - 2025
MA State Medical License 2004 - 2015- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 2 citationsAvoiding Treatment in Hospital With Subcutaneous Furosemide for Worsening Heart Failure: A Pilot Study (AT HOME-HF).Marvin A Konstam, Joseph Massaro, Ravi Dhingra, Mary Walsh, Linda Ordway
JACC. Heart Failure. 2024-11-01 - Assessing the Impact of Posaconazole Cessation on Tacrolimus Serum Concentrations and Incident Cardiac Allograft Rejection: Take Caution.Ethan Meyer, Ravi Dhingra, Theodore Berei
Journal of Pharmacy Practice. 2024-10-01 - 6 citationsSurveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry.Kiran Khush, Shelley Hall, Andrew Kao, Nirav Raval, Ravi Dhingra
The Journal of Heart and Lung Transplantation. 2024-09-01
Press Mentions
Patients Who Receive Heart Transplants from Donors Who Use Illicit Drugs Have Unaffected Survival RatesJuly 29th, 2021- Hearts from Donors Who Used Drugs or Died of Overdoses Safe for TransplantationJuly 28th, 2021
- Transplanting Hearts from Drug Users Is Safe, Could Shorten WaitJuly 28th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
